HCV RNA (quantitative PCR)
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BIO-HCV-RNA |
|---|---|
| Type | Biomarker |
| Aliases | HCV PCRHCV RNA by quantitative PCRHCV viral loadРНК HCV (кількісна ПЛР) |
| Status | reviewed 2026-04-24 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-EASL-HCV-2023 |
Biomarker Facts
| Biomarker type | viral_load |
|---|---|
| Measurement | MethodReal-time quantitative PCR UnitsIU/mL Typical range
|
| Related biomarkers | None declared |
Notes
Binary positive/negative used for Indication applicability; quantitative value tracked for antiviral response assessment (SVR12 = undetectable at week 12 post-treatment).
Used By
Algorithms
ALGO-HCV-MZL-1L- ALGO-HCV-MZL-1LALGO-HCV-MZL-2L- ALGO-HCV-MZL-2L
Biomarker
BIO-HCV-STATUS- HCV status (anti-HCV antibody screening)
Indications
IND-DLBCL-1L-POLA-R-CHP- IND-DLBCL-1L-POLA-R-CHPIND-DLBCL-1L-RCHOP- IND-DLBCL-1L-RCHOPIND-HCC-SYSTEMIC-1L-ATEZO-BEV- IND-HCC-SYSTEMIC-1L-ATEZO-BEVIND-HCV-MZL-1L-ANTIVIRAL- IND-HCV-MZL-1L-ANTIVIRALIND-HCV-MZL-1L-BR-AGGRESSIVE- IND-HCV-MZL-1L-BR-AGGRESSIVEIND-MM-1L-DARA-RD- IND-MM-1L-DARA-RDIND-MM-1L-DVRD- IND-MM-1L-DVRDIND-NMZL-1L-HCV-POSITIVE- IND-NMZL-1L-HCV-POSITIVEIND-SMZL-1L-HCV-POSITIVE- IND-SMZL-1L-HCV-POSITIVE
Questionnaires
QUEST-HCV-MZL-1L- HCV-associated Marginal Zone Lymphoma — first lineQUEST-NODAL-MZL-1L-STUB- Nodal Marginal Zone Lymphoma — first lineQUEST-SPLENIC-MZL-1L-STUB- Splenic Marginal Zone Lymphoma — first line